跳至主要内容
临床试验/NCT01977521
NCT01977521Unknown不适用

Transcranial Direct Current Stimulation as Treatment for Auditory Hallucinations A Sham-controlled Trial

Iris Sommer2 个研究点 分布在 1 个国家目标入组 62 人开始时间: 2014年4月最近更新:
适应症

试验速览

阶段
不适用
发起方
Iris Sommer
入组人数
62
试验地点
2
主要终点
Total score of the Auditory Hallucination Rating Scale (AHRS) questionnaire

研究概览

简要总结

The present study aims to examine the efficacy of transcranial direct current stimulation on the severity of auditory hallucinations.

详细描述

Rationale: Auditory hallucinations (AH) are a symptom of several psychiatric disorders, such as schizophrenia. In the majority of patients, these AH respond well to antipsychotic medication. Yet, a significant minority continues to experience frequent AH despite optimal pharmacotherapy and AH severely decrease quality of life in these patients. The number of alternative treatment options for this medication resistant group is currently low and most of them focus on coping with the hallucinations. Transcranial direct current stimulation (tDCS), in contrast, is a safe, non-invasive technique that is able to directly influence cortical excitability through the application of very low electric currents. This technique has only a few transient side-effects and is cheap and portable. To date, only one randomized controlled trial has been published, suggesting high efficacy of tDCS for the treatment of medication-resistant AH in a relatively small sample. We aim to replicate and extend these findings by investigating the efficacy of this technique in a larger sample.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Frequent auditory hallucinations (at least 5 times a week).
  • Patients are on a stable dose of antipsychotic medication (which can also be zero) for at least 2 weeks
  • Mentally competent for informed consent.
  • Provided informed consent.

排除标准

  • Metal objects in or around the head that cannot be removed (i.e. cochlear implant, surgical clips, piercing)
  • History of seizures, or a history of seizures in first-degree relatives.
  • History of eye trauma with a metal object or professional metal workers
  • History of brain surgery, brain infarction, head trauma, cerebrovascular accident, broken skull, brain tumour, heart disease, cardiac pacemaker.
  • Skin disease on the scalp on the position of the tDCS electrodes
  • Coercive treatment based on a judicial ruling
  • Pregnancy in female patients

结局指标

主要结局

Total score of the Auditory Hallucination Rating Scale (AHRS) questionnaire

时间窗: 4 years

The primary outcome is the change in the severity of the hallucinations before and after the treatment, as experienced by the participant, measured with the Auditory Hallucination Rating Scale (AHRS)

次要结局

  • Changes in severity of hallucinations as assessed by the hallucination change scale (HCS)questionnaire(4 years)
  • Changes of positive, negative and disorganized symptomatology as assessed by the positive and negative syndrome scale (PANSS)(4 years)
  • Severity of psychotic symptoms will be measured by the questionnaire for psychotic symptoms (QPS)(4 years)
  • Prior expectations regarding the efficacy of the treatment of the participants(4 years)
  • Strength of the motor threshold as assessed using TMS(4 years)
  • The presence and severity of side-effects will be monitored using the tDCS adverse effects questionnaire(4 years)
  • Interference score on the Stroop task(4 years)
  • Score on the Trailmaking test A and B(4 years)

研究者

发起方
Iris Sommer
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Iris Sommer

Professor, Psychiatrist

UMC Utrecht

研究点 (2)

Loading locations...

相似试验